Metformin Aurobindo (Metformin Hydrochloride)

Metformin Hydrochloride reduces hepatic glucose production, limits intestinal glucose absorption, and improves peripheral insulin sensitivity. By acting on the liver, gut, and muscle cells, it lowers circulating glucose without directly stimulating insulin secretion, which contributes to a lower risk of hypoglycemia when used alone.

The exact dosage of Metformin Aurobindo is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions without self‑adjusting the dose.

Safety of metformin during pregnancy or lactation should be evaluated by a qualified clinician. While some guidelines allow limited use when benefits outweigh risks, the decision is individualized. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and alternatives with their healthcare provider.

To request Metformin Aurobindo, visit the product page on gnhindia.com and submit an enquiry specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with sulfonylureas or insulin, metformin lowers glucose without stimulating insulin release, resulting in a lower intrinsic risk of hypoglycemia. It also promotes modest weight loss and has cardiovascular benefits in many patients. However, it may be less potent in rapidly reducing very high glucose levels, where combination therapy might be required.

Metformin Aurobindo should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the packaging.

Metformin Aurobindo is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a full glass of water and should not be crushed or chewed unless specifically instructed by a healthcare professional. Adherence to the prescribed schedule is essential for optimal glycemic control.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or conditions causing hypoxia. Other serious concerns include severe skin reactions such as Stevens‑Johnson syndrome and significant vitamin B12 deficiency with long‑term use. Prompt medical attention is required if symptoms arise.

Metformin Aurobindo is contraindicated in individuals with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in patients receiving iodinated contrast studies without adequate renal function assessment. Clinicians should also exercise caution in patients with liver disease or heart failure.